Key Points
- Director Christopher Kuebler sold 3,626 Waters shares at an average price of $397.94, generating approximately $1.44 million; his remaining stake declined 16.92% to 17,808 shares.
- Waters exceeded quarterly expectations, reporting $3.05 in EPS versus $3.01 expected and $1.65 billion in revenue versus $1.62 billion expected. Revenue rose 113.3% year over year, and the company issued full-year 2026 EPS guidance of $14.45–$14.65.
- Analysts maintain a “Moderate Buy” consensus with an average price target of $418.10, while institutional investors own 94.01% of the company’s shares.
Waters Corporation (NYSE:WAT - Get Free Report) Director Christopher Kuebler sold 3,626 shares of the business's stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the sale, the director owned 17,808 shares of the company's stock, valued at $7,086,515.52. This trade represents a 16.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Waters Stock Performance
Shares of NYSE WAT opened at $406.94 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.77 and a quick ratio of 1.13. The firm has a market cap of $39.96 billion, a price-to-earnings ratio of 101.48, a P/E/G ratio of 2.32 and a beta of 1.19. The stock's fifty day moving average price is $373.23 and its two-hundred day moving average price is $345.56. Waters Corporation has a one year low of $275.05 and a one year high of $414.15.
Waters (NYSE:WAT - Get Free Report) last posted its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share for the quarter, topping analysts' consensus estimates of $3.01 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%.The company's revenue was up 113.3% on a year-over-year basis. During the same quarter last year, the firm earned $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. On average, equities analysts forecast that Waters Corporation will post 14.57 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on the stock. Morgan Stanley set a $430.00 price objective on shares of Waters in a report on Wednesday. Barclays raised their target price on shares of Waters from $425.00 to $460.00 and gave the stock an "overweight" rating in a report on Wednesday. Guggenheim reiterated a "buy" rating and issued a $440.00 price target on shares of Waters in a research report on Wednesday, July 8th. Wolfe Research began coverage on Waters in a research note on Tuesday, June 2nd. They issued an "outperform" rating and a $425.00 price target for the company. Finally, JPMorgan Chase & Co. increased their price target on Waters from $330.00 to $345.00 and gave the stock a "neutral" rating in a research report on Wednesday, May 6th. Three research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $418.10.
View Our Latest Report on Waters
Institutional Investors Weigh In On Waters
Several institutional investors and hedge funds have recently bought and sold shares of the company. M. Kulyk & Associates LLC acquired a new stake in Waters during the second quarter worth about $217,000. Meeder Advisory Services Inc. acquired a new position in shares of Waters in the 2nd quarter valued at approximately $896,000. Citizens Financial Group Inc. RI acquired a new position in shares of Waters in the 2nd quarter valued at approximately $370,000. Nuance Investments LLC bought a new stake in shares of Waters during the 2nd quarter worth approximately $4,036,000. Finally, Grandfield & Dodd LLC bought a new stake in shares of Waters during the 2nd quarter worth approximately $690,000. Institutional investors own 94.01% of the company's stock.
Waters Company Profile
(
Get Free Report)
Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.
Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
